Consistently, we observed a significant reduction of total caspase-6 and -7 in three subtypes of breast cancer cell lines after combination treatment, suggesting that caspase-6 and -7 might be involved in the induction of synergistic pro-apoptotic activities. The gene discussed is CASP6; the disease is breast cancer.